Dubai, UAE – August 11, 2025 —As part of the UAE’s 2025 “Year of Community” initiative, Astra Partners collaborated with Senses Residential and Day Care for Special Needs to offer a powerful and inspiring experience for a group of People of Determination (PODs). On Saturday, 9 August 2025, the children visited “The Messi Experience: A Dream Come True” at Dubai Festival City Mall, an immersive and interactive exhibition showcasing the extraordinary career of football legend Lionel Messi.
The initiative not only reflected the spirit of inclusion, but also served as a powerful reminder of how thoughtful collaborations can inspire confidence, unity, and joy within the community.
Nisus Finance is currently evaluating acquisition of US$200 million worth of ready residential projects in Dubai to accelerate its partnership with BNWDevelopments
Dubai, UAE; August 11, 2025: Nisus Finance Investment Consultancy FZCO (NiFCO Dubai), a fully owned subsidiary of Nisus Finance Services Co Limited (NiFCO), announced a strategic partnership with the UAE’s leading developer BNW Developments that is set to redefine the real estate experience for end-users and investors alike.
NiFCO Dubai has launched the Nisus High Yield Growth Fund Closed-Ended IC, a Dubai International Financial Centre (DIFC) registered property fund, incorporated under the laws of the DIFC, and an incorporated cell of Gateway ICC Limited with the Gateway Investment Management Services (DIFC) Limited as the Fund Manager.
The Sharjah Clinical Genomics Laboratory in the UK is advancing research and bringing hope to thousands of cancer patients
A humanitarian initiative by HH Sheikha Jawaher Al Qasimi, the lab was established with a £500,000 donation
One of only two UK labs selected by NHS England to evaluate long-read whole genome sequencing for clinical application.
Enhancing lung cancer genetic mutation analysis using ‘Liquid Biopsy’ technology
Capacity has been doubled to deliver an additional ,000 genetic tests monthly
Actively participating in clinical trials for DNA-based personalised therapies
The Royal Marsden is a specialist cancer centre that brings together world class researchers and dedicated clinical teams providing expert compassionate care
Sharjah, August 11, 2025,
The Royal Marsden Cancer Charity; which supports the work of The Royal Marsden; has commended the significant support of Her Highness Sheikha Jawaher bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah and Founder/Royal Patron of the Friends of Cancer Patients (FoCP). Its annual report highlighted her contributions to advancing cancer research, particularly through initiatives over the past five years that have accelerated progress at the Sharjah Clinical Genomics Laboratory within the National Institute for Health and Care Research (NIHR) Centre for Molecular Pathology (CMP); housed within The Royal Marsden in the UK. These efforts have greatly enhanced faster delivery of precise diagnoses and cutting-edge personalised treatments for patients.
The report underscored that Her Highness’s support has empowered the lab’s scientific team to fast-track diagnostics and treatments, bringing hope to thousands of patients. This was achieved through the introduction of state-of-the art facilities to the Sharjah Clinical Genomics Laboratory; including the UK’s first robotic genome testing facility; and bringing together world experts in molecular pathology, bioinformatics, translational research.
India, 11th August 2025: Eyestem Research Pvt Ltd has raised funds in a significantly oversubscribed funding round to support the next stage of development for its investigational retinal pigment epithelial (RPE) cell therapy, Eyecyte-RPE™.
The capital will enable completion of the ongoing Phase 2 clinical trial in India and support preparations for filing an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA).
“Strong participation by internal investors and addition of a strategic investor, underline the shared belief in Eyestem’s long-term vision of creating an innovative cell therapy platform providing scalable solutions for incurable diseases worldwide. This $10 million fundraise will support the next leg of development and strengthen the foundation for global expansion. We continue to prioritize rigorous clinical progress and the capabilities needed to ensure global patient access to this therapy,” said Dr. Jogin Desai, Founder and CEO, Eyestem.
(L to R) Dr Jogin Desai, Dr Rajani Battu & Dr Rajarshi Pal
Dubai, United Arab Emirates August 2025:Axis Communications announces two multifunctional display speakers designed to reach more people through combined visual and audio alerts. Featuring an attention-grabbing strobe bar, powerful speaker, and a colour text display, these versatile indoor solutions raise the bar for clear public address in schools, healthcare facilities, transportation hubs, and more.
AXIS C1710 Network Display Speaker and the dual-sided corridor model, AXIS C1720 Network Display Speaker, are suited for general public address as well as urgent messaging. Built on open standards, AXIS C17 Series integrates with third-party mass notification systems to ensure effective communication when it matters most.
UAE News 24/7 